摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(methoxymethyl)-1H-thieno[3,4-d]imidazole | 1421787-20-3

中文名称
——
中文别名
——
英文名称
2-(methoxymethyl)-1H-thieno[3,4-d]imidazole
英文别名
——
2-(methoxymethyl)-1H-thieno[3,4-d]imidazole化学式
CAS
1421787-20-3
化学式
C7H8N2OS
mdl
——
分子量
168.219
InChiKey
SFAANQMRASILRF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    66.2
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    2-(methoxymethyl)-1H-thieno[3,4-d]imidazole(E)-2-(8-(bromomethyl)-3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene)propanenitrile 以obtained in Reference Example 1的产率得到(E)-2-(3-fluoro-8-{[2-(methoxymethyl)-1H-thieno[3,4-d]imidazol-1-yl]methyl}dibenzo[b,e]oxepin-11(6H)-ylidene)propanenitrile
    参考文献:
    名称:
    DIBENZOOXEPIN DERIVATIVE
    摘要:
    提供以下一种二苯并噁呤衍生物,其通式为(I),其中Y为氢原子等,RA为氢原子等,X为式(b3),其中RB为氢原子等,A为式(a18),其中R1为氢原子等,RC和RD相同或不同,每个均为氢原子等等,该化合物具有PPARγ激动剂活性等,并且可用作治疗和/或预防2型糖尿病等的治疗剂和/或预防剂等,或其药学上可接受的盐等。
    公开号:
    US20140163008A1
  • 作为产物:
    描述:
    ethyl 2-methoxyacetimidate monohydrochloride3,4-diaminothiophene dihydrochloride三乙胺 作用下, 以 乙醇 为溶剂, 反应 70.0h, 以58%的产率得到2-(methoxymethyl)-1H-thieno[3,4-d]imidazole
    参考文献:
    名称:
    DIBENZOOXEPIN DERIVATIVE
    摘要:
    公开号:
    EP2740730B1
点击查看最新优质反应信息

文献信息

  • US8969345B2
    申请人:——
    公开号:US8969345B2
    公开(公告)日:2015-03-03
  • DIBENZOOXEPIN DERIVATIVE
    申请人:Kyowa Hakko Kirin Co., Ltd.
    公开号:EP2740730B1
    公开(公告)日:2016-11-16
  • Dibenzooxepin derivative
    申请人:Yamamoto Keisuke
    公开号:US08969345B2
    公开(公告)日:2015-03-03
    A dibenzoxepin derivative represented by the following general formula (I) wherein Y is a hydrogen atom and the like, RA is a hydrogen atom and the like, X is the formula (b3) wherein RB is a hydrogen atom and the like, and the like, A is the formula (a18) wherein R1 is a hydrogen atom and the like, and RC and RD are the same or different and each is a hydrogen atom and the like, and the like, which has a PPARγ agonist activity and the like, and useful as a therapeutic agent and/or prophylaxis agent and the like for type 2 diabetes and the like, or a pharmaceutically acceptable salt thereof and the like is provided.
    提供了一种二苯并氧吩衍生物,其通式表示为(I),其中Y为氢原子等,RA为氢原子等,X为式(b3),其中RB为氢原子等,A为式(a18),其中R1为氢原子等,RC和RD相同或不同,且每个为氢原子等,该物质具有PPARγ激动剂活性等,可用作治疗和/或预防2型糖尿病等的治疗剂和/或预防剂等,或其药学上可接受的盐等。
查看更多

同类化合物

沙维拉唑 4H-吡咯并[1,2-a]噻吩并[3,2-D]咪唑 3H-噻吩并[2,3-d]咪唑-5-羧酸 3-甲基-1H-噻吩并[2,3-d]咪唑-2(3h)-酮 2-(氯甲基)-1H-噻吩并[3,4-d]咪唑 1H-噻吩并[3,2-D]咪唑-2(3H)-酮 1H-噻吩并[2,3-d]咪唑,1-乙烯基-(9CI) 1H-噻吩并(3,4-d)咪唑,2-(((5-甲基-2-吡啶基)甲基)亚硫酰基)- 1-甲基-1H-噻吩并[2,3-D]咪唑基-2(3H)-酮 1-乙烯基-1H-噻吩并[2,3-d]咪唑-5-羧酸 1,3-二氢噻吩并[3,4-d]咪唑-2-硫酮 tert-butyl 4-[4-(2,3-dihydro-2-oxo-1-tert-butoxycarbonyl-1H-thieno[3,4-d]imidazol-4-yl)phenyl]-2,3-dihydro-2-oxo-1H-thieno[3,4-d]imidazole-1-carboxylate 2-(3-Bromo-4-methoxy-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole 2-[3-Methoxy-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethylsulfanyl]-1H-thieno[3,4-d]imidazole 2-(2-diethylaminobenzylmercapto)-1H-thieno[3,4-d]imidazole 2-(5-Bromo-4-methoxy-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole 2-(5-Chloro-4-methoxy-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole 2-(2-dimethylaminobenzylmercapto)-1H-thieno[3,4-d]imidazole 6-amino-1-vinylthieno[2,3-d]imidazole-5-carboxamide 1-Vinyl-1H-thieno[2,3-d]imidazole-5-carboxylic acid ethyl ester 2-(3-Chloro-pyridin-2-ylmethanesulfinyl)-1H-thieno[3,4-d]imidazole 2-(5-Methoxy-pyridin-2-ylmethanesulfinyl)-1H-thieno[3,4-d]imidazole (2S,4S)-tert-butyl 2-(5-(4-bromophenyl)-1H-thieno[2,3-d]imidazol-2-yl)-4-methylpyrrolidine-1-carboxylate 1-methyl-2-methoxymethyl-thieno[2.3-d]imidazol-5-yl-carboxylic acid 2-(3-Fluoro-pyridin-2-ylmethanesulfinyl)-1H-thieno[3,4-d]imidazole 2-(4-Benzyloxy-pyridin-2-ylmethanesulfinyl)-1H-thieno[3,4-d]imidazole 2-(4-methoxy-2-picolylsulfinyl)-1H-thieno[3,4-d]imidazole 2-[(4-methoxypyridin-2-yl)methylsulfinyl]-1H-thieno[2,3-d]imidazole 4-(4-methoxyphenyl)-2-[(4-methoxypyridin-2-yl)methylsulfinyl]-1H-thieno[3,4-d]imidazole 2-(4-methoxy-2-picolylmercapto)-1H-thieno[3,4-d]imidazole methyl 2-[(4-methoxypyridin-2-yl)methylsulfanyl]-1H-thieno[3,4-d]imidazole-4-carboxylate 2-[(4-methoxypyridin-2-yl)methylsulfinyl]-4-phenyl-1H-thieno[3,4-d]imidazole dimethyl 2-[(4-methoxypyridin-2-yl)methylsulfinyl]-1H-thieno[2,3-d]imidazole-5,6-dicarboxylate 2-[(4-methoxypyridin-2-yl)methylsulfanyl]-1H-thieno[2,3-d]imidazole methyl 2-[(4-methoxypyridin-2-yl)methylsulfinyl]-1H-thieno[3,4-d]imidazole-4-carboxylate 1-Ethoxycarbonyl-2-(4-methoxy-2-picolylsulfinyl)-1H-thieno[3,4-d]imidazole 1-ethoxycarbonyl-2-(4-methoxy-2-picolylmercapto)-1H-thieno[3,4-d]imidazole ethyl 2-methylthieno[2,3-d]imidazol-5-carboxylate 2-[(5-chloropyridin-2-yl)methylsulfinyl]-1H-thieno[3,4-d]imidazole 2-[(4-Thiazolyl)methylthio]thieno[3,4-d]imidazole 2-[[3-Methoxy-4-(2,2,3,3,4,4,4-heptafluorobutoxy)-2-pyridinyl]methylsulfinyl]-1H-thieno[3,4-d]imidazole 2-[(3-methoxypyridin-2-yl)methylsulfinyl]-1H-thieno[3,4-d]imidazole 2-[(3,4-dimethoxypyridin-2-yl)methylsulfanyl]-1H-thieno[3,4-d]imidazole 2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-thieno[3,4-d]imidazole 2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-4-(4-methoxyphenyl)-1H-thieno[3,4-d]imidazole 2-(4-methoxy-3,5-dimethyl-2-picolylsulfinyl)-1H-thieno[3,4-d]imidazole 2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-4-phenyl-1H-thieno[3,4-d]imidazole 2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-1H-thieno[3,4-d]imidazole (3S,3'S,5S,5'S)-tert-butyl 5,5'-(5,5'-(buta-1,3-diyne-1,4-diyl)bis(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-thieno[2,3-d]imidazole-5,2-diyl))bis(3-methylpyrrolidine-1-carboxylate) (2S,4S)-tert-butyl 2-(5-ethynyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-thieno[2,3-d]imidazol-2-yl)-4-methylpyrrolidine-1-carboxylate